Polymeric ruthenium precursor as a photoactivated antimicrobial agent

Highlights: • Polymeric dicarbonyldichlororuthenium (II) shows high antibacterial activity. • This polymeric precursor is prepared in a straightforward synthesis without the use of expensive hydrophobic ligands. • Antimicrobial activity of [Ru(CO)₂Cl₂]_n can be significantly boosted under photoirradiation. • [Ru(CO)₂Cl₂]_n is biocompatible to non-tumoral cells at bactericidal concentration. • The generation of reactive oxygen species under UV light inhibits the bacterial growth. Ruthenium coordination compounds have demonstrated a promising anticancer and antibacterial activity, but their poor water solubility and low stability under physiological conditions may limit their therapeutic applications. Physical encapsulation or covalent conjugation with polymers may overcome these drawbacks, but generally involve multistep reactions and purification processes. In this work, the antibacterial activity of the polymeric precursor dicarbonyldichlororuthenium (II) [Ru(CO)₂Cl₂]_n has been studied against Escherichia coli and Staphylococcus aureus. This Ru-carbonyl precursor shows minimum inhibitory concentration at nanogram per millilitre, which renders it a novel antimicrobial polymer without any organic ligands. Besides, [Ru(CO)₂Cl₂]_n antimicrobial activity is markedly boosted under photoirradiation, which can be ascribed to the enhanced generation of reactive oxygen species under UV irradiation. [Ru(CO)₂Cl₂]_n has been able to inhibit bacterial growth via the disruption of bacterial membranes and triggering upregulation of stress responses as shown in microscopic measurements. The activity of polymeric ruthenium as an antibacterial material is significant even at 6.6 ng/mL while remaining biocompatible to the mammalian cells at much higher concentrations. This study proves that this simple precursor, [Ru(CO)₂Cl₂]_n, can be used as an antimicrobial compound with high activity and a low toxicity profile in the context of need for new antimicrobial agents to fight bacterial infections.